Skip to content

Visit tso.co.uk

Quick Search

Search by:

Evidence Check 2: Homeopathy

HC 45, Fourth Report of Session 2009-10 - Report, Together with Formal Minutes, Oral and Written Evidence

Author:
House of Commons - Science and Technology Committee
Publisher:
TSO (The Stationery Office)
Price: £24.50
Add to Basket
Evidence Check 2: Homeopathy - Front

'Evidence Check 2: Homeopathy (HC 45)' examines the Government's policies on the provision of homeopathy through the National Health Service (NHS) and the licensing of homeopathic products by the Medicines and Healthcare products Regulatory Agency (MHRA). This was prompted after a Government response in September 2009 indicated that scientific evidence was not used to formulate the licensing regime operated by the MHRA.

This inquiry is an examination of the evidence behind government policies on homeopathy, not an inquiry into homeopathy. The task was to determine whether scientific evidence supports government policies.

The Government acknowledges that there is no credible evidence of efficacy for homeopathy however this view has not translated into evidence-based policies. The Committee states that by providing homeopathy on the NHS and allowing MHRA licensing of products which subsequently appear on pharmacy shelves the Government runs the risk of endorsing homeopathy as efficacious. The Committee concludes that homeopathy should not be funded on the NHS and the MHRA should stop licensing homeopathic products.

Extent 271 pages ISBN 9780215544100
Size A4 Price £24.50
Format Paperback Published 22 Feb 2010
Availability Colour copy: 3 - 5 days Availability help (opens in new window) Delivery Delivery options and charges
Bookmark and Share
Save
Add to Basket

Related titles:

Evidence Check 1: Early Literacy Interventions – HC 44

Save
Add to Basket

Visit the TSO Parliamentary and Legal Bookshop

ITIL - Service Management

PRINCE2

BRC - British Retail Consortium

DSA - Learning to Drive

IiP - Investors in People

Follow TSO Publications on Twitter

Secure Site by Verisign - click to verify